CliffBio
small molecule

VICODIN ES

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameVICODIN ES
Active ingredientACETAMINOPHEN; HYDROCODONE BITARTRATE
Strength750MG;7.5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1988
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

VICODIN ES patent cliff — loss of exclusivity — | CliffBio